Phototherapy for hypopigmented mycosis fungoides in Asians
- 1 July 2012
- journal article
- clinical trial
- Published by Wiley in Photodermatology, Photoimmunology & Photomedicine
- Vol. 28 (4) , 181-186
Abstract
Hypopigmented mycosis fungoides (MF) is an uncommon variant of MF. It is rare in Caucasians but more common in young skin-of-color individuals. To date, there are only a few reports on UV-based treatment for this condition. To analyze the efficacy of PUVA photochemotherapy and narrowband UVB (NBUVB) phototherapy for hypopigmented MF. A retrospective study of nine patients who received PUVA or NBUVB was performed. The clinical response, total number of treatments, cumulative UV doses, disease-free interval and adverse effects were recorded. Eight patients had stage IA and one patient had stage IB. Six patients received NBUVB and three patients received PUVA. Three patients (50%) in the NBUVB group and three patients (100%) in the PUVA group had complete response (CR). Total UV dose to get maximal clinical response ranged from 27.1-59.6 J/cm(2) in the NBUVB group and 244-669.1 J/cm(2) in the PUVA group. In six patients who had CR, recurrence was found in four (66.7%), and the disease-free interval ranged from 2 months to 6 years. PUVA and NBUVB are effective for hypopigmented MF. Comparing between these two methods, PUVA provided a better response than NBUVB. Although the disease responded well to phototherapy, relapse was common.Keywords
This publication has 25 references indexed in Scilit:
- Phototherapy of mycosis fungoidesPhotodermatology, Photoimmunology & Photomedicine, 2011
- A study of clinicopathologic profile of 15 cases of hypopigmented mycosis fungoidesIndian Journal of Dermatology, Venereology and Leprology, 2011
- Efficacy of narrowband UVB vs. PUVA in patients with early‐stage mycosis fungoidesJournal of the European Academy of Dermatology and Venereology, 2010
- Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)Blood, 2007
- Retrospective 5‐year review of 131 patients with mycosis fungoides and Sézary syndrome seen at the National Skin Centre, SingaporeAustralasian Journal of Dermatology, 2006
- Narrowband UVB phototherapy for early‐stage mycosis fungoides: evaluation of clinical and histopathological changesJournal of the European Academy of Dermatology and Venereology, 2006
- EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndromeEuropean Journal of Cancer, 2006
- Narrow-band UVB in the treatment of early stage mycosis fungoides: report of 16 patientsClinical and Experimental Dermatology, 2005
- Hypopigmented variant of mycosis fungoides: Demography, histopathology, and treatment of seven casesJournal of the American Academy of Dermatology, 1995
- Can mycosis fungoides begin in the epidermis? A hypothesisBritish Journal of Dermatology, 1973